Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Chalkias S, Dennis P, Petersen D, Radhakrishnan K, et al. Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial. Lancet Infect Dis 2025 Jul 7:S1473-3099(25)00236.
PMID: 40639387


Privacy Policy